Clinical Trials on Cancer Sequelae in Netherlands

Total 1711 results

The Netherlands Cancer Institute
Seagen Inc.

Recruiting

Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study (TRAIN-4)

Breast Cancer

Netherlands
Academisch Ziekenhuis Maastricht

Recruiting

Perioperative Energy Expenditure in Major Liver Resection (PRO-NRG)

Liver Diseases | Cancer | Liver Neoplasms

Netherlands
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO (BELLINI)

Breast Cancer

Netherlands
UMC Utrecht

Withdrawn

Efficacy of MR-HIFU Ablation of Breast Cancer

Breast Cancer

Netherlands
University Medical Center Groningen

Completed

Web-based Screening and Tailored Support (ENCOURAGE)

Breast Cancer

Netherlands
European Organisation for Research and Treatment...
Sanofi; Novartis; Roche Pharma AG; Breast International Group; Agendia

Completed

Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes (MINDACT)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer (Oligo)

Breast Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients

Breast Cancer

Netherlands
Leiden University Medical Center

Completed

Effects of Short-term Fasting on Tolerance to Chemotherapy

Breast Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Merck Sharp & Dohme LLC; PTC Therapeutics

Recruiting

Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study (ATAPEMBRO)

Colorectal Cancer | Endometrium Cancer

Netherlands
Amsterdam UMC, location VUmc
Medtronic - MITG

Recruiting

COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation (COLLISION)

Surgery | Liver Metastases | ColoRectal Cancer | Liver Metastasis Colon Cancer

Netherlands
Erasmus Medical Center

Recruiting

ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI) (START-TKI)

Non Small Cell Lung Cancer | Liquid Biopsy | Tyrosine Kinase Inhibitor

Netherlands
University Medical Center Groningen
Human Genome Sciences Inc.

Completed

Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer

Advanced Cervical Cancer

Netherlands
Leiden University Medical Center

Completed

Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma

Thyroid Cancer

Netherlands
Bas P. L. Wijnhoven

Recruiting

Surgery As Needed for Oesophageal Cancer - 2 (SANO-2)

Cancer of Esophagus

Netherlands
Radboud University Medical Center
Astellas Pharma Europe B.V.

Completed

Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment Response (ILUMINATE)

Metastatic Castration Resistant Prostate Cancer

Netherlands
University Medical Center Groningen

Recruiting

Standard Follow-up Program (SFP) for Head and Neck Cancer Patients (H&NTOX)

Head and Neck Cancer

Netherlands
Amsterdam UMC, location VUmc

Recruiting

[18F]F-AraG PET Imaging to Visualize Tumor Infiltrating T-cell Activation in Non-small Cell Lung Cancer. (ATTAIN)

Non-Small Cell Lung Cancer

Netherlands
University Medical Center Groningen

Completed

89Zr-trastuzumab PET for Imaging the Effect of HSP90 Inhibition (AUY922)

Breast Cancer

Netherlands
University Medical Center Groningen

Recruiting

Standard Follow-up Program Cervix Cancer (SFP CERVIX) (SFPCERVIX)

Cervical Cancer Radiation Complications

Netherlands
UMC Utrecht

Completed

Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node Metastases (Node)

Adenocarcinoma | Cancer | Squamous Cell Carcinoma | Malignancy

Netherlands
The Netherlands Cancer Institute
Eli Lilly and Company; Universitaire Ziekenhuizen KU Leuven; European Organisation... and other collaborators

Withdrawn

Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)

Colorectal Cancer Metastatic

Netherlands
Philips Healthcare

Completed

Optical Detection of Malignancy During Percutaneous Interventions

Breast Cancer | Colon Cancer Liver Metastasis | Pulmonary Coin Lesion

Netherlands
Modra Pharmaceuticals
The Netherlands Cancer Institute

Completed

ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer

Castration-resistant Prostate Cancer

Netherlands
Erasmus Medical Center

Recruiting

TEIPP Immunotherapy in Patients With NSCLC (TEIPP)

Non Small Cell Lung Cancer

Netherlands
Erasmus Medical Center

Recruiting

Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC (HAMLET)

Non-small Cell Lung Cancer

Netherlands
Radboud University Medical Center

Recruiting

Micro-Tech FNB Needle to Obtain Tissue Specimens of Pancreas Malignancy for Personalized Based Chemotherapy (MT-FNB)

Pancreatic Cancer

Netherlands
Sander van Hootegem

Completed

The Diagnostic Value of Staging Laparoscopy and Computed Tomography Response Assessment in Patients With Gastric Adenocarcinoma

Gastric Cancer

Netherlands
Maastricht Radiation Oncology

Completed

PET With [18F]HX4 in Head and Neck Cancer

Cancer of the Head and Neck

Netherlands
Maastricht University Medical Center

Completed

Treatment of Pain in Head-and-Neck Cancer Patients: is Methadone More Effective? (310111-4)

Pain | Cancer of Head and Neck

Netherlands
Maastricht Radiation Oncology
National Cancer Institute (NCI); Maastricht University Medical Center

Terminated

Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients (Chloroquine IV)

Small Cell Lung Cancer

Netherlands
Bayer

Completed

A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants

Healthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 Mutation

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Chemoradiation and Panitumumab for Esophageal Cancer

Adenocarcinoma | Esophageal Cancer | Squamous Cell Carcinoma | Gastro-esophageal Junction Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer (B-DOCT)

Metastatic Gastric Cancer | Adenocarcinoma of the Gastro-oesophageal Junction

Netherlands
University Medical Center Groningen

Completed

FDHT PET and Bicalutamide in Metastatic Breast Cancer

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy

Prostate Cancer

Netherlands
Radboud University Medical Center
Siemens Corporation, Corporate Technology; Biolitec; Soteria Medical

Recruiting

MRI-guided Focal Laser Ablation (Unicorn)

Prostate Cancer

Netherlands
Radboud University Medical Center

Completed

Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake (SNACK)

Prostate Cancer

Netherlands
Dutch Colorectal Cancer Group
Roche Pharma AG; The Netherlands Cancer Institute

Active, not recruiting

Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)

Gastric Cancer

Netherlands
Erasmus Medical Center
University Medical Center Groningen; Leiden University Medical Center

Recruiting

FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test (FUTURE)

Advanced Breast Cancer

Netherlands
Amsterdam UMC, location VUmc

Recruiting

PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer

Pancreatic Cancer | Metastatic Pancreatic Cancer

Netherlands
University Medical Center Groningen

Enrolling by invitation

Standard Follow-up Program (SFP) for Breast Cancer Patients (SFPMAMMA)

Breast Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer (TRAP-2)

Esophageal Cancer | Esophageal Adenocarcinoma

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer (VENETIA)

Bleeding | Venous Thromboembolism | Chemotherapy Effect | Esophagus Cancer

Netherlands
Radboud University Medical Center
St. Antonius Hospital; The Netherlands Cancer Institute; Canisius-Wilhelmina...

Recruiting

Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance (MINIVAB)

Breast Cancer

Netherlands
Maastricht Radiation Oncology
Maastricht University

Completed

Prone Breast Irradiation for Pendulous Breasts

Breast Cancer

Netherlands
Zuyderland Medisch Centrum

Completed

Seroma Reduction After Mastectomy (SAM)

Breast Cancer | Seroma | Aspiration

Netherlands
Maastricht University Medical Center

Completed

Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer

Breast Cancer | Breast Neoplasms

Netherlands
Maastricht Radiation Oncology
Maastricht University Medical Center; Atrium Medical Center; Maasland Hospital

Completed

Pre-operative Contrast Enhanced CT to Improve Delineation of the Tumorbed in Radiotherapy for Breast Cancer.

Breast Cancer

Netherlands
Leiden University Medical Center
University Medical Center Groningen

Completed

Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer (CHIP)

Recurrent Ovarian Cancer

Netherlands

Clinical Trials on Cancer Sequelae in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations